Legends to Supplementary Tables & Figures
Electrophysiological parameters used to sub-classify PVN neurons in ex vivo brain slice preparations.
Data are from: type Ia: n = 17; type Ib: n = 5; type IIa: n = 10; type IIb: n = 7; type IIIa: n = 18; type IIIb: n = 16 neurons, and were expressed as means ± s.e.m. Parameters were chosen according to published protocols (Miyoshi et al, 2010) . Sub-clustering was based on the posthoc identification of biocytin-filled neurons using AVP/oxytocin (combined in triple-labeling experiments and used as "magnocellular markers") and secretagogin (scgn) as histochemical markers (see also Fig. 3A ,B).
Suppl. Table 2
List of primary antibodies used for multiple immunofluorescence labeling.
All antibodies were affinity purified, and extensively tested in vitro and in vivo, including relevant genetic controls (Benoit et al, 1980; Mulder et al, 2009; Hartig et al, 2009; Westberg et al, 2009; Dabrowska et al, 2011; Stanic et al, 2011; Attems et al, 2012; Shi et al, 2012; Renner et al, 2012; Keimpema et al, 2013) . 
Suppl.

Suppl. Figure 1
Electrophysiological classification of PVN neurons.
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Suppl. Figure 2
Secretagogin-expressing PVN neurons exhibit parvocellular identities, including dendrite morphology. responses (ratiometric measurements by using Fura-2AM) from n ≥ 3 neurons/group exposed to depolarizing conditions (55 mM KCl).
Suppl. Figure 3
The effect of secretagogin on pharmacologically-induced Ca 
Suppl. Figure 5
In vivo siRNA-mediated secretagogin silencing does not affect prominent hormone and neuropeptide systems in the mouse paraventricular nucleus.
(A) Arginine-vasopressin (AVP)-immunoreactive PVN neurons showed unchanged distribution in adult mice that had been injected with secretagogin-specific siRNA in the paraventricular nucleus ("scgn siRNA") relative to control animals ("non-target siRNA"). 
